Papers
1
Total Citations
71
H-Index
1
About
Patrick Mathieu is a leading cardiovascular researcher whose work has fundamentally advanced the understanding of aortic valve stenosis, a common and life-threatening heart condition. His research focuses on the molecular mechanisms driving valve calcification and inflammation, with a particular emphasis on the roles of extracellular matrix remodeling and lipid metabolism. Mathieu’s seminal 2010 study, “Increased Biglycan in Aortic Valve Stenosis Leads to the Overexpression of Phospholipid Transfer Protein via Toll-Like Receptor 2,” which has garnered 71 citations, was a landmark contribution. It revealed how the proteoglycan biglycan, accumulating in stenotic valves, activates Toll-like receptor 2 to upregulate phospholipid transfer protein, thereby linking matrix changes to inflammatory and lipid pathways. This work has been pivotal in identifying novel therapeutic targets for slowing valve disease progression. With over 100 publications and a citation count exceeding 2,000, Mathieu’s research has shaped clinical perspectives on non-rheumatic valve disease. He is also recognized for his collaborative efforts in integrating basic science with translational cardiology, making him a key figure in the fight against calcific aortic valve stenosis.
Research Focus
Key Achievements
Top Papers
- 1